W.O.M. World of Medicine AG

EANS-News: W.O.M. World of Medicine AG
Change from Prime Standard to General Standard

@@start.t1@@--------------------------------------------------------------------------------   Corporate news transmitted by euro adhoc. The issuer/originator is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Company Information

Berlin (euro adhoc) - Shares issued by W.O.M. WORLD OF MEDICINE AG (ISIN: DE0006637390) are approved for trading on the regulated market of the Frankfurt Stock Exchange, with simultaneous admission to the section of the regulated market associated with additional follow-up obligations (Prime Standard).

The Management Board of W.O.M. WORLD OF MEDICINE AG has agreed to change the company´s exchange listing from the Prime Standard of the regulated market to the General Standard of the regulated market of the Frankfurt Stock Exchange. An application was yesterday made to the Frankfurt Stock Exchange for the revocation of admission of company shares to the Prime Standard.

The revocation of admission will become effective after three months following the publication on the Internet of the revocation decision by the management of the stock exchange (www.deutsche-boerse.com). It does not affect the admission of W.O.M. WORLD OF MEDICINE AG shares to the regulated market (General Standard).

WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive Surgery - or MIS( for short. This approach includes safe and gentle surgical procedures conducted not through major incisions, but through keyhole or puncture incisions. The Company is the global market leader in a niche of this future market.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: W.O.M. World of Medicine AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Stefanie Gehrke
Cell Phone: + 49 (0) 172 402 67 40
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    CDAX, Prime All Share, Technology All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              München / free trade



Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: